# OnCo record paper-drup-van-der-velden-nature-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-drup-van-der-velden-nature-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-drup-van-der-velden-nature-2019" ;
  schema:name "The Drug Rediscovery Protocol: approved cancer drugs used outside their licence, inside a national trial"@en ;
  schema:description "The first report of the Dutch DRUP trial: a third of 215 patients with no standard options left benefited from an approved drug matched to their tumour's molecular profile and given outside its licence."@en ;
  schema:url <https://onco.cc/key-papers/paper-drup-van-der-velden-nature-2019/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41586-019-1600-x>, <https://pubmed.ncbi.nlm.nih.gov/31570881/> ;
  schema:sameAs <https://doi.org/10.1038/s41586-019-1600-x> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "van der Velden DL, Hoes LR, van der Wijngaart H, et al." ;
  onco:related <https://onco.cc/key-papers/paper-priestley-hartwig-metastatic-wgs-nature-2019/> ;
  onco:companies <https://onco.cc/companies/hartwig-medical-foundation/> ;
  onco:institutions <https://onco.cc/institutions/nki/>, <https://onco.cc/institutions/oncode-institute/> ;
  onco:trials <https://onco.cc/trials/drup/> ;
  onco:people <https://onco.cc/people/emile-voest/>, <https://onco.cc/people/myriam-chalabi/> .